Oxford Nanopore

PITCH

Our goal is to enable the analysis of any living thing, by anyone, anywhere. Oxford Nanopore’s goal is to enable the analysis of any living thing, by anyone, anywhere. The Company has developed the world's first and only nanopore DNA sequencing platform, which is uniquely scalable from pocket-sized formats through to ultra-high throughput devices. The technology offers real-time data analysis for rapid, dynamic insights; the ability to sequence any length fragments of DNA or RNA, whether short or ultra-long, and the ability to sequence native molecules for rich data that includes real-time epigenetic information.

Based in

Oxford

Created in

> Website

LATEST INVESTMENT

#Biotech 05.2021

£195M

M&G Investments & Others

#Healthtech 10.2020

Oxford Nanopore

£84.4M

Invesco Perpetual, Woodford Investment Management, Top Technology Ventures, IP Group PLC, Illumina, Odey Asset Management, China Construction Bank, Hostplus, GIC and Lansdowne Partners